NYSE - Delayed Quote USD
Zoetis Inc. (ZTS)
155.99
+6.12
+(4.08%)
At close: May 7 at 4:00:02 PM EDT
156.94
+0.95
+(0.61%)
Pre-Market: 6:23:41 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 17 | 17 |
| Avg. Estimate | 1.6 | 1.64 | 6.16 | 6.77 |
| Low Estimate | 1.56 | 1.56 | 6.05 | 6.27 |
| High Estimate | 1.66 | 1.68 | 6.26 | 7.34 |
| Year Ago EPS | 1.56 | 1.58 | 5.92 | 6.16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 13 | 16 |
| Avg. Estimate | 2.41B | 2.43B | 9.45B | 10.02B |
| Low Estimate | 2.35B | 2.4B | 9.35B | 9.74B |
| High Estimate | 2.43B | 2.46B | 9.53B | 10.2B |
| Year Ago Sales | 2.36B | 2.39B | 9.26B | 9.45B |
| Sales Growth (year/est) | 1.90% | 1.69% | 2.09% | 6.08% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 1.48 | 1.46 | 1.36 | 1.4 |
| EPS Actual | 1.56 | 1.58 | 1.4 | 1.48 |
| Difference | 0.08 | 0.12 | 0.04 | 0.08 |
| Surprise % | 5.30% | 8.03% | 2.84% | 5.79% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.6 | 1.64 | 6.16 | 6.77 |
| 7 Days Ago | 1.6 | 1.62 | 6.06 | 6.74 |
| 30 Days Ago | 1.6 | 1.62 | 6.09 | 6.78 |
| 60 Days Ago | 1.6 | 1.62 | 6.07 | 6.83 |
| 90 Days Ago | 1.65 | 1.69 | 6.36 | 7.08 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 2 | 3 | 2 |
| Down Last 7 Days | 1 | 1 | 2 | 2 |
| Down Last 30 Days | 3 | 2 | 3 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZTS | 2.74% | 3.76% | 4.06% | 9.84% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | UBS: Neutral to Neutral | 5/7/2025 |
| Maintains | Stifel: Buy to Buy | 4/14/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/27/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/14/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/14/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/10/2025 |
Related Tickers
ELAN Elanco Animal Health Incorporated
12.01
+26.29%
LNTH Lantheus Holdings, Inc.
80.49
-23.23%
NBIX Neurocrine Biosciences, Inc.
121.61
+2.26%
UTHR United Therapeutics Corporation
306.92
+4.03%
TEVA Teva Pharmaceutical Industries Limited
17.60
+9.18%
VTRS Viatris Inc.
8.60
+1.42%
BCRX BioCryst Pharmaceuticals, Inc.
10.08
-1.85%
RGC Regencell Bioscience Holdings Limited
189.99
+25.82%
PRGO Perrigo Company plc
26.41
+7.01%
HLN Haleon plc
10.76
+0.84%